Pfizer ( PFE 0.22%) is a case in point, with its forward dividend yield of 7%. Although the stock is a favorite for many income investors, questions about the sustainability of the dividend persist.

Pfizer › Pfizer (NYSE: PFE) has been a terrible investment over the past three years. Revenue and earnings have generally ...

Pfizer delivered a strong Q2 earnings beat, raising FY2025 guidance and demonstrating effective cost-cutting. Learn why PFE ...

The tariff threat come just a few days after the White House sent letters to major drugmakers demanding slashed prices for US ...

If you are looking for dividend stocks, a good place to start is with unloved stocks like these, with yields of up to 6.4%.

The Cubs acquired pitcher Mike Soroka from the Nationals for two prospects and reliever Andrew Kittredge from the Orioles for another prospect.

Pfizer has beaten its earnings per share (EPS) estimates in its past 12 quarters. Beating EPS estimates hasn't always meant positive movements for Pfizer's share price. The stock's low valuation ...

Bristol-Myers Squibb (BMY) shares rise after beating Q2 forecasts, raising 2025 revenue outlook, and showcasing growth in key ...

Just how big Pfizer will be is hard to say. There's a lot of negativity about the company's prospects baked into its share price, with the stock trading at only 8.3 times forward earnings.

When leading a turnaround, you’re tasked with charting a path forward for an organization in serious decline. It’s a high-stakes moment that requires a hard look at what’s no longer working ...

If the Red Sox want to add a top talent before Thursday's trade deadline, Boston might have to give up a top prospect or two.